Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage
Open Access
- 18 January 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (1) , 124-129
- https://doi.org/10.1002/1529-0131(200201)46:1<124::aid-art10121>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mechanisms involved in cartilage proteoglycan catabolismMatrix Biology, 2000
- The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of ChondrogenesisThe Journal of Experimental Medicine, 2000
- Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitroBiochemical Journal, 1999
- Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytesMatrix Biology, 1999
- Differential Expression of Aggrecanase and Matrix Metalloproteinase Activity in Chondrocytes Isolated from Bovine and Porcine Articular CartilageJournal of Biological Chemistry, 1998
- Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction.Genes & Development, 1997
- Cyclosporin A. Mode of Action and Effects on Bone and Joint TissuesScandinavian Journal of Rheumatology, 1992
- A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cellsNucleic Acids Research, 1991
- Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin aArthritis & Rheumatism, 1990
- Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell ActivationScience, 1989